Target intelligence / Profile preview

NLR family CARD domain-containing protein 4 and Absent in melanoma 2 inflammasome complexes (NLRC4/AIM2 inflammasome)

Target
NLRC4/AIM2 inflammasome
Molecular classification
Pattern recognition receptor (PRR), Multiprotein complex, NLR family, PYHIN family, Inflammasome
01

Overview

The NLRC4 and AIM2 inflammasome complexes are critical components of the innate immune system that function as intracellular sensors for pathogens and cellular stress. NLRC4 (NLR family CARD domain-containing protein 4) is primarily activated by bacterial components such as flagellin and type III secretion system (T3SS) proteins, while AIM2 (Absent in melanoma 2) recognizes double-stranded DNA (dsDNA) from both viral and bacterial sources. Upon activation, these proteins recruit the adapter protein ASC and the protease Caspase-1 to form a large multiprotein complex, leading to the maturation of pro-inflammatory cytokines IL-1beta and IL-18 and the induction of pyroptosis, a form of programmed inflammatory cell death. Dysregulation of these complexes is linked to severe autoinflammatory conditions, such as NLRC4-associated macrophage activation syndrome (MAS), and plays a role in the progression of various cancers and autoimmune disorders. Therapeutic strategies targeting these complexes often focus on inhibiting Caspase-1 or blocking the downstream effects of the released cytokines to mitigate chronic inflammation.

Other names
IPAF (ICE protease-activating factor)CLANPYHIN4Absent in melanoma 2NLR family CARD domain-containing protein 4NLRC4-AIM2 supramolecular complex
02

Mechanism of action

Inhibition of Caspase-1 activity, prevention of ASC speck formation, or blockade of downstream pro-inflammatory cytokines (IL-1beta and IL-18).

03

Biological functions

Immune responseInflammationPyroptosisCytokine processing (IL-1beta, IL-18)Pathogen sensingProteolysis
04

Disease associations

Autoinflammatory disease (e.g., NLRC4-MAS)Infection (Bacterial and Viral)CancerAutoimmune diseaseSystemic lupus erythematosusMacrophage activation syndrome
05

Safety considerations

Increased susceptibility to bacterial and viral infectionsImmunosuppressionPotential for impaired wound healingRisk of opportunistic infections
06

Interacting drugs

Belnacasan (VX-765)

4 more in the full profile.

07

Biomarkers

Interleukin-1 beta (IL-1beta)Interleukin-18 (IL-18)ASC specksCaspase-1 activityLactate dehydrogenase (LDH) release

Beyond the preview

Go deeper on NLR family CARD domain-containing protein 4 and Absent in melanoma 2 inflammasome complexes (NLRC4/AIM2 inflammasome).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NLR family CARD domain-containing protein 4 and Absent in melanoma 2 inflammasome complexes (NLRC4/AIM2 inflammasome).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call